Tenax Therapeutics (TENX) EPS (Basic) (2010 - 2026)
Tenax Therapeutics (TENX) reported EPS (Basic) of -$1.89 for Q1 2026, down 565.36% on a YoY basis from $0.41 in Q1 2025, and down 378.06% sequentially from -$0.4 in Q4 2025.
Tenax Therapeutics (TENX) EPS (Basic) (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 17 years of EPS (Basic) data on file, last reported at -$1.89 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 565.36% year-over-year to -$1.89; the trailing twelve-month figure through Mar 2026 stood at -$3.07 (down 363.65% YoY), and the FY2025 full-year result was -$2.63, up 32.37% from the prior year.
- EPS (Basic) eased to -$1.89 in Q1 2026, from -$0.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $165.19 in Q2 2022 to a low of -$172.75 in Q1 2022.
- A 5-year average of $13.34 and a median of -$0.41 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 102.87% in 2022 and slumped 565.36% in 2026, its largest moves.
- Tracing TENX's EPS (Basic) over 5 years: stood at $138.91 in 2022, then sank by 135.58% to -$49.42 in 2023, then jumped by 99.17% to -$0.41 in 2024, then increased by 3.49% to -$0.4 in 2025, then plunged by 378.06% to -$1.89 in 2026.
- Business Quant data shows TENX's EPS (Basic) at -$1.89 in Q1 2026, -$0.4 in Q4 2025, and -$0.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | -1.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.89 |
| Dec 31, 2025 | -0.40 |
| Sep 30, 2025 | -0.67 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.19 |
| Jun 30, 2024 | -1.83 |
| Mar 31, 2024 | -3.12 |
| Dec 31, 2023 | -49.42 |
| Sep 30, 2023 | 6.54 |
| Jun 30, 2023 | -4.00 |
| Mar 31, 2023 | -12.10 |
| Dec 31, 2022 | 138.91 |
| Sep 30, 2022 | 163.46 |
| Jun 30, 2022 | 165.19 |
| Mar 31, 2022 | -172.75 |
| Dec 31, 2021 | -4,839.80 |
| Sep 30, 2021 | 218.97 |
| Jun 30, 2021 | 170.79 |